adenosquamous carcinoma


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to adenosquamous carcinoma: adenocarcinoma

ad·e·no·squa·mous car·ci·no·ma

a type of lung tumor exhibiting areas of clear-cut glandular and squamous cell differentiation.

adenosquamous carcinoma

A malignancy seen on the sun-exposed head and neck of the elderly, which may arise in a prior squamous cell carcinoma and tends to have a poorer prognosis.

adenosquamous carcinoma

a primary epithelial bronchogenic tumor.
References in periodicals archive ?
The differential diagnosis of adenosquamous carcinoma includes squamous cell carcinoma and mucoepidermoid carcinoma.
In no case was adenosquamous carcinoma correctly diagnosed.
If TTF-1 and p40 or p63 positivity are seen in different populations of tumor cells, it is possible this may be more suggestive of adenosquamous carcinoma than if these markers are coexpressed in the same tumor cells.
EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.
The type of lung cancer in these cases was adenocarcinoma in 7 cases, squamous cell carcinoma in 1 case, undifferentiated large cell carcinoma in 1 case, and adenosquamous carcinoma in 1 case.
Recognition of adenosquamous carcinoma is clinically important because it is associated with worse survival than adenocarcinomas.
The bronchiolar histotype could also be assigned to cases in which adenocarcinoma cells are admixed with a squamous component derived from the same clone, as observed in adenosquamous carcinoma, (106) and probably also the recently described basal-type adenocarcinoma.
6; and combined adenocarcinoma and adenosquamous carcinomas, 0.
56) and adenocarcinoma plus adenosquamous carcinomas (OR, 0.
Notably, Binder et al cited the misclassification of high-grade mucoepidermoid carcinomas as adenosquamous carcinomas.
Positive NTRK2 staining also occurs less frequently in large cell neuroendocrine tumors (2 of 6), adenosquamous carcinomas (1 of 3), and large cell carcinomas (4 of 55), and rarely in adenocarcinomas (11 of 236) and carcinoid tumors (1 of 93).
64) Depending on the myoepithelial marker that was used, between 15% and 20% of invasive mammary carcinomas appear to fall into the triple-negative immunophenotypic group, with the latter including most typical and atypical medullary carcinomas, metaplastic carcinomas, conventional myoepithelial-type carcinomas (such as low-grade adenosquamous carcinomas, malignant adenomyoepithelioma, and myoepithelial carcinomas), and others.